Novavax Income Tax Expense from 2010 to 2024

NVAX Stock  USD 8.47  0.43  5.35%   
Novavax Income Tax Expense yearly trend continues to be fairly stable with very little volatility. Income Tax Expense will likely drop to about 1.8 M in 2024. During the period from 2010 to 2024, Novavax Income Tax Expense regression line of annual values had significance of  0.13 and arithmetic mean of  2,602,605. View All Fundamentals
 
Income Tax Expense  
First Reported
1996-03-31
Previous Quarter
2.2 M
Current Value
-1 M
Quarterly Volatility
5.9 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novavax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novavax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.3 M, Interest Expense of 15.1 M or Selling General Administrative of 499.1 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0066 or Days Sales Outstanding of 82.31. Novavax financial statements analysis is a perfect complement when working with Novavax Valuation or Volatility modules.
  
Check out the analysis of Novavax Correlation against competitors.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Latest Novavax's Income Tax Expense Growth Pattern

Below is the plot of the Income Tax Expense of Novavax over the last few years. It is Novavax's Income Tax Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novavax's overall financial position and show how it may be relating to other accounts over time.
Income Tax Expense10 Years Trend
Slightly volatile
   Income Tax Expense   
       Timeline  

Novavax Income Tax Expense Regression Statistics

Arithmetic Mean2,602,605
Coefficient Of Variation316.58
Mean Deviation4,659,358
Median1,358,000
Standard Deviation8,239,276
Sample Variance67.9T
Range35.6M
R-Value0.41
Mean Square Error61.1T
R-Squared0.16
Significance0.13
Slope748,163
Total Sum of Squares950.4T

Novavax Income Tax Expense History

20241.8 M
2023M
20224.3 M
202129.2 M
20209.2 M
2019-2.6 M
20181.4 M

About Novavax Financial Statements

Novavax investors use historical fundamental indicators, such as Novavax's Income Tax Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novavax. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Income Tax ExpenseM1.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.